Korea Investment CORP increased its position in shares of The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 50.3% during the 4th quarter, HoldingsChannel reports. The fund owned 89,915 shares of the medical device company’s stock after acquiring an additional 30,100 shares during the quarter. Korea Investment CORP’s holdings in Cooper Companies were worth $8,266,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently bought and sold shares of the company. LPL Financial LLC increased its position in shares of Cooper Companies by 12.5% during the 4th quarter. LPL Financial LLC now owns 141,604 shares of the medical device company’s stock worth $13,018,000 after purchasing an additional 15,746 shares during the last quarter. Simplify Asset Management Inc. increased its position in shares of Cooper Companies by 78.1% during the fourth quarter. Simplify Asset Management Inc. now owns 15,793 shares of the medical device company’s stock valued at $1,452,000 after acquiring an additional 6,925 shares during the last quarter. KLP Kapitalforvaltning AS purchased a new stake in shares of Cooper Companies in the 4th quarter valued at approximately $6,086,000. Sei Investments Co. lifted its holdings in shares of Cooper Companies by 2.7% in the 4th quarter. Sei Investments Co. now owns 293,265 shares of the medical device company’s stock worth $26,961,000 after acquiring an additional 7,798 shares during the last quarter. Finally, American Century Companies Inc. boosted its position in shares of Cooper Companies by 0.9% during the 4th quarter. American Century Companies Inc. now owns 45,210 shares of the medical device company’s stock worth $4,156,000 after purchasing an additional 412 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of analysts have issued reports on COO shares. Needham & Company LLC reissued a “hold” rating on shares of Cooper Companies in a research report on Friday, March 7th. StockNews.com lowered Cooper Companies from a “buy” rating to a “hold” rating in a research note on Wednesday, December 11th. JPMorgan Chase & Co. dropped their target price on Cooper Companies from $120.00 to $110.00 and set an “overweight” rating for the company in a research report on Friday, March 7th. Wells Fargo & Company boosted their price target on shares of Cooper Companies from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Friday, December 6th. Finally, Piper Sandler reissued an “overweight” rating and issued a $115.00 price objective (down previously from $120.00) on shares of Cooper Companies in a research note on Friday, March 7th. Four investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $110.25.
Cooper Companies Stock Up 0.7 %
Cooper Companies stock opened at $84.35 on Tuesday. The stock has a 50 day moving average of $89.15 and a two-hundred day moving average of $97.03. The Cooper Companies, Inc. has a twelve month low of $77.05 and a twelve month high of $112.38. The stock has a market capitalization of $16.87 billion, a price-to-earnings ratio of 43.26, a PEG ratio of 2.25 and a beta of 1.02. The company has a current ratio of 1.91, a quick ratio of 1.12 and a debt-to-equity ratio of 0.32.
Cooper Companies (NASDAQ:COO – Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share for the quarter, hitting the consensus estimate of $0.92. The firm had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. As a group, research analysts expect that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.
About Cooper Companies
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Stories
- Five stocks we like better than Cooper Companies
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Buyable Stocks With Solid Bottoms Ready to Rebound
- Investing in Travel Stocks Benefits
- Advantage+ Shopping: Meta’s Fast Growing $20 Billion AI-Ads Star
- Ride Out The Recession With These Dividend Kings
- Robotaxi News: What Tesla and Lyft Headlines Mean for Shares
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.